The human cost of Herceptin - how other cancer patients pay the price

Doctors have calculated that their trust will have to cut £2.3 million from cancer services to implement NICE guidance on Herceptin.

Herceptin
Herceptin

New guidance from NICE recommends trastuzumab (Herceptin) in early breast cancer but provides no extra funding.

Doctors at the Norfolk and Norwich University Hospital NHS Trust and the University of East Anglia said they would have to find £1.9 million a year to make Herceptin available to the patients who may be eligible. This becomes £2.3 million when the costs of testing and monitoring patients are added.

After auditing drug costs in their hospital’s cancer centre, they estimated that they could save £1.9 million by cutting chemotherapy and palliative care treatments.

This would enable them to treat 75 patients with Herceptin, but they would have to stop 355 patients receiving adjuvant treatment (16 of whom would be cured) or 208 patients receiving palliative chemotherapy.

Writing in the BMJ, the doctors argue that NICE should be given responsibility to decide what to cut to fund newly recommended technologies, or have the ability to allocate extra funds, rather than leaving rationing decisions to medical staff.

MIMS link

Cancer

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Viewpoint: Why NICE guidance on domestic abuse needs to be updated

Dr Vasumathy Sivarajasingam explains why screening for domestic abuse should be standard...

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

PCNs opt out of phase 2 of COVID-19 vaccination programme over workload pressure

Some PCNs have opted out of phase 2 of the COVID-19 vaccination programme, with others...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

CVT risk from COVID-19 infection 'significantly higher' than from vaccines, study suggests

The risk of cerebral venous thrombosis (CVT) following COVID-19 infection is eight...

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

‘Warm and kind’ retired Derbyshire GP dies from COVID-19

Retired Derbyshire GP Dr Om Prakash Chawla, who was known for his warmth and kindness,...

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

GPs can learn from pandemic to strengthen relationship with patients, says RCGP chair

General practice can build on changes to care during the COVID-19 pandemic to strengthen...